The role of changes in blood-brain barrier permeability in the pathogenesis of hepatic encephalopathy remains uncertain. To test the hypothesis that brain microvessel permeability is nonselectively increased in hepatic encephalopathy we measured the blood-brain barrier permeability-surface area product in rats with acute liver failure induced by intraperitoneal injection of galactosamine. The permeability-surface area products to the diffusion-limited tracers, sucrose and methylaminoisobutyric acid, were determined as a measure of blood-brain barrier permeability. Animals were examined 24,36 and 42 hr after injection, at times when they were stuporous, but not comatose. No significant elevations of the permeability-surface area products for either compound were detected in clinically affected experimental animals when compared to controls. Our results indicate there is no generalized increase in brain vascular permeability during hepatic insufficiency in precomatose animals.
ured more accurately with a technique developed by Ohno et al. (8) . The BBB permeability-surface area product (PS) is determined following an intravenous injection of radiolabeled sucrose. The sucrose content in brain can be corrected for the intravascular portion by determining brain blood volume in a separate group of animals. We used this method to test the hypothesis that there is a generalized increase in BBB permeability during galactosamine-induced liver failure.
MATERIALS AND METHODS
Male Sprague-Dawley rats weighing 250 to 350 gm were given an intraperitoneal injection of D+ galactosamine hydrochloride (3 gm per kg) as a 0.28 M solution (pH 7.4) in water (9, 10). Control animals were injected with 0.28 M glucose in water. The animals were fed standard laboratory chow and 10 gm% glucose was added to their water.
At 24, 36 and 42 hr after the galactosamine injection, the animals were anesthetized with sodium pentobarbital (50 mg per kg, i. p.) and tracheotomized. Polyethylene catheters were inserted into all four femoral vessels. The left femoral artery catheter was connected to a blood pressure transducer to monitor blood pressure as well as to collect blood-gas samples. The right femoral artery catheter was connected to a peristaltic pump to permit continuous arterial blood withdrawal. One venous catheter was used for intravenous injection of drugs while the other intravenous catheter was used for injection of radioactive tracers. The animals were paralyzed with gallamine, and ventilated using a volume ventilator set to maintain the arterial pC0, between 35 and 45 mm Hg. Temperature was monitored by a rectal probe and maintained at 36.5" to 37.5'C with an incandescent lamp.
Serum enzyme and bilirubin assays were performed in the clinical laboratory of the Columbus Children's Hospital using a Kodak Ektachem-700'" analyzer.
For measurement of both BBB permeability (PS) and cerebral blood volume, the animals were allowed to reach a steady state 15 to 30 min following cannulation. Radioactive tracers were injected intravenously. During PS determinations, arterial blood was withdrawn from the right femoral artery at a known rate. When a predetermined amount of time had elapsed, a terminal arterial blood sample was collected from the left femoral artery, the animal was decapitated and the continuous arterial withdrawal was stopped. The forebrain was separated into right and left halves, then divided into cerebral hemispheres and basal ganglia. The brainstem was separated from the cerebellum. The brain regions were placed in preweighed scintillation vials containing Protosol and General Procedures.
Injection of Isotopes.
reweighed. Blood from the continuous arterial withdrawal was expelled into a preweighed vial, weighed and 50 p1 aliquots were placed in scintillation vials containing a 2: 1 (volume/volume) mixture of ethano1:Protosol. The terminal arterial blood hematocrit was measured, and 50-pl aliquots of the blood were also dissolved in ethano1:Protosol. Brain and blood samples were heated at 65°C until they were digested. The blood samples were bleached with 50 pl 30% hydrogen peroxide. Toluenebased scintillation cocktail was added to all samples, and the amount of radioisotope present was assayed by liquid scintillation using single or double channels as appropriate.
Regional brain plasma volume and red blood cell volume were determined using a variation of a method previously described (11, 12) . Homologous rat red blood cells were incubated with 300 pCi 51Cr per 1.2 ml packed cells for 30 min at 37°C. The labeled red cells were then washed three times with iced phosphate-buffered saline (PBS) containing 10 mM glucose and kept on ice. Just prior to use, a 200-pl aliquot of cells was washed with PBS and suspended with 100 .ul 1% bovine serum albumin (BSA) in PBS containing 10 pCi '"I-labeled BSA (1.39 pCi per mg BSA). The suspension was injected via the left femoral venous line. The labeled cells and plasma were allowed to circulate for 2 min, then a terminal arterial blood sample was rapidly withdrawn and the animal was decapitated. The samples were subsequently handled as described in the general procedures. The radioactive content was determined in a two-channel liquid scintillation counter that was calibrated for simultaneous counting of the Auger and conversion electrons emitted by "Cr and "' I (13) . Typical counting efficiencies were 20 and 20% for channel A, and 1 and 33% for channel B, for "Cr and '9, Cdculotions. Assuming that the PS for sucrose or MAIB is much less than the regional cerebral blood flow, and that the early brain concentration of either isotope is negligibly small (7), PS may be determined by the following relationship:
Blood Volume Meaeurement.
where CI, = the amount of' isotope in the brain region and C. = the amount of isotope in the arterial blood at a given time, t. The integral of C.dt between the time of isotope injection and termination of' the experiment can be estimated by using a continuous arterial withdrawal at a known rate using the following equation:
where C., = total amount of isotope in the arterial blood sample and F,, = the withdrawal rate of the pump (14) . Knowing the tissue plasma volume (PV), the following relationship can be made:
where C, = the terminal arterial concentration of isotope and Hct,, = the arterial hematocrit. PV is calculated from the lollowing equation using Hct. and values for regional blood volume (BV) and the ratio (R) of tissue to peripheral hematocrits determined in a separate group of animals:
Thus, the plasma volume term takes into account any variability in peripheral hematocrits between groups of animals. 
S t a t i s t i d A d y e i s .
Results were assumed to be random samples that were mutually independent under the experimental conditions. Because of small sample sizes, a normal distribution was not assumed, and nonparametric statistical tests were selected. For the data in Tables 1 to 4 , results from three experimental animal groups were compared simultaneously with controls by the Kruskal-Wallis test using a = 0.01. For comparisons of the single MAIB uptake group to controls, the Mann-Whitney rank sum test was employed using the same a = 0.01 (15, 16) . Basal ganglia 10.6 f 1.7 11.3 f 0.4 10.9 f 0.6 10.3 f 2.6 Cerebellum 11.1 f 0.7 10.2 f 0.8 9.2 f 1.6 9.7 f 2.1 Brainstem 9.6 f 2.4 10.6 f 2.2 8.8 f 1.9 10.4 f 2.3
Each value is the mean f S.D. of determinations for five animals. In ml/gm/min x 10'.
RESULTS
At 24 hr after administration of galactosamine, the urine and plasma of the experimental rats were icteric, but the animals showed no behavioral difference from control animals. By 36 hr, the animals were listless, and they startled easily. A t 42 hr, the rats were awake, but poorly responsive to the environment. By this time, two animals had died after a period of irritability followed by stimulus-induced tonic seizures. When physiological parameters were compared, animals at 36 to 42 hr were more acidotic and hypotensive than the 24-hr experimental rats (Table 1) .
We measured serum aminotransferases, and total and direct bilirubin to characterize the extent of liver damage. In animals injected with glucose, values for AST, ALT, total bilirubin and direct bilirubin remained constant for at least 48 hr after injection (data not shown). In animals injected with galactosamine, serum aminotransferases steadily rose to a maximum at 36 hr after galactosamine injection and declined by 42 hr, although the aminotransferase levels remained greater than control values (Table  2) . Serum direct bilirubin steadily increased above control values after galactosamine injection at all time points measured. All values at 24,36 and 42 hr were significantly different from controls (p < 0.01). The pronounced rise in serum aminotransferases and the progressing hyperbilirubinemia point to the severity of galactosamineinduced hepatic injury. No significant increases from control values were noted in tissue plasma volumes, red cell volumes, blood volumes and tissue hematocrits in the cortex, basal ganglia, cerebellum and brainstem of galactosamine-treated animals at 24,36 or 42 hr (Table 3) . Brain blood volumes, expressed as microliters per gram of brain weight, did not vary with body weight in the animals examined (comparison not shown). The only multiple sample comparisons that approached significance were an increase in tissue red cell volumes for the cortex (p = 0.037) and the brainstem (p = 0.049) when results at different time points were compared to controls. The differences were most notable between controls and 24-hr animals than at other times.
PS was calculated for sucrose using the blood volumes shown in Table 2 . At all times following galactosamine injection, PS for affected animals did not differ significantly from controls (Table 4) . This was true at 24 hr when animals were behaviorly unaffected as well as at 36 and 42 hr wheh their behavior was distinctly abnormal.
Other investigators have reported significant increases in the regional PS product for aminoisobutyric acid in galactosamine-treated rabbits (2). In order to determine whether this observation was the result of a specific change in brain uptake of this type of amino acid analog, we determined the PS product for MAIB in rats 24 hr after galactosamine administration. We found no increase in PS for MAIB compared to controls. In fact, the MAIB-PS in all regions was lower than control (Table  5) . While MAIB enters the brain very poorly, it'is possible that a portion of its brain uptake is mediated by an amino acid transport system. Reduced brain uptake of MAIB in galactosamine-treated rats might, therefore, be explained by competition for transport from the elevated plasma concentrations of other neutral amino acids during hepatic failure (17) . 
DISCUSSION
During the course of galactosamine-induced acute hepatic failure, we found no change in BBB permeability to sucrose despite the increasing duration of hepatic injury and progressive alterations in behavior. During the times studied, all animals showed evidence of severe liver damage. By 36 hr, they were less active and by 42 hr they were either lethargic or hyperirritable, but not comatose.
Our results are in agreement with other studies which found no change in BBB permeability following liver injury. In one study, rats with chronic portacaval shunts were given ammonium acetate to acutely induce encephalopathy (4). There was no difference in the brain uptake of sucrose compared with controls. A second study used a similar method without ammonia loading; no change in the BBB permeability to inulin was found (5). A third study found no change in brain uptake of "Na and "Cr-EDTA in rats examined 3 weeks after the creation of a portacaval shunt (6). These three studies used the intracarotid bolus injection method to measure the brain uptake index, although this technique is relatively insensitive to changes in BBB permeability for poorly diffusible compounds. In a fourth study, Mans et al. (18) used the technique of quantitative autoradiography, which is more sensitive than the brain uptake index technique to determine BBB permeability to sucrose. They found no change in PS in rats examined 7 to 8 weeks after portacaval shunting. Mans et al. did not examine BBB changes during acute hepatic encephalopathy.
Our findings conflict with the observations of Zaki et al.
(1) who employed the brain uptake index technique in galactosamine-induced hepatic failure and hepatic devascularization. They detected a 3-to 4-fold increase in the uptake of inulin and a %fold increase in the uptake of sucrose and L-glucose. The animals were examined in deep coma and were, therefore, more severely affected than the animals in the present study. It is possible, as those authors point out, that the detected changes in
